Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001654954-17-007580
Filing Date
2017-08-14
Accepted
2017-08-14 17:01:22
Documents
45
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT aols_10q.htm 10-Q 592501
2 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF aols_ex311.htm EX-31.1 10776
3 CERTIFICATION PURSUANT TO RULE 13A-14(A)/15D-14(A) CERTIFICATIONS SECTION 302 OF aols_ex312.htm EX-31.2 11003
4 CERTIFICATE PURSUANT TO SECTION 18 U.S.C. PURSUANT TO SECTION 906 OF THE SARBANE aols_ex321.htm EX-32.1 8218
  Complete submission text file 0001654954-17-007580.txt   2899981

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT aols-20170630.xml EX-101.INS 603149
6 XBRL TAXONOMY EXTENSION SCHEMA aols-20170630.xsd EX-101.SCH 33864
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aols-20170630_cal.xml EX-101.CAL 25924
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aols-20170630_def.xml EX-101.DEF 97605
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE aols-20170630_lab.xml EX-101.LAB 225915
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aols-20170630_pre.xml EX-101.PRE 163584
Mailing Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691
Business Address 26361 CROWN VALLEY PARKWAY, SUITE 150 MISSION VIEJO CA 92691 9494819825
AEOLUS PHARMACEUTICALS, INC. (Filer) CIK: 0001261734 (see all company filings)

EIN.: 561953785 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 000-50481 | Film No.: 171031331
SIC: 2834 Pharmaceutical Preparations